Literature DB >> 18694861

Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes.

Nikolaos Vitoratos1, Georgios Valsamakis, George Mastorakos, Anastassios Boutsiadis, Nikolaos Salakos, Evagelia Kouskouni, George Creatsas.   

Abstract

OBJECTIVE: To investigate maternal serum adiponectin and Interleukin-1beta (IL-1beta) levels during the pre- and post-partum periods in pregnant women with and without gestational diabetes mellitus (GDM).
DESIGN: Thirty control pregnant Caucasian women without GDM and thirty body mass index (BMI) and age-matched Caucasian women with GDM examined in the outpatient clinic between the 24th and 26th week of their pregnancy and on the 3rd day postpartum underwent anthropometry and had serum blood taken. Both groups, were monitored by a dietitian and had comparable weight gain during pregnancy. Birth weight was also measured.
RESULTS: At the 3rd day postpartum, compared to the 2nd trimester of pregnancy, women with GDM had lower serum adiponectin levels, lower serum IL-1beta levels and lower homeostasis model assessment for insulin resistance (HOMA-IR) values. At the 2nd trimester of pregnancy, women with GDM had lower serum adiponectin levels, higher IL-1beta and higher HOMA-IR values compared to women without GDM. At the 3rd day postpartum, women with GDM had lower serum adiponectin levels, higher IL-1beta and higher HOMA-IR values compared to women without GDM. Second trimester serum adiponectin values of women with GDM correlated negatively with birth weight.
CONCLUSIONS: Gestational diabetes is a state of insulin resistance associated with altered levels of proinflammatory cytokines, increased IL-1beta and decreased adiponectin values. Both of these alterations might be attributed to placental pathology in pregnancies with GDM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694861     DOI: 10.14310/horm.2002.1202

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  13 in total

1.  Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells.

Authors:  Luigia Di Francesco; Melania Dovizio; Annalisa Trenti; Emanuela Marcantoni; Ashleigh Moore; Peadar O'Gaora; Cathal McCarthy; Stefania Tacconelli; Annalisa Bruno; Sara Alberti; Salvatore Gizzo; Giovanni Battista Nardelli; Genny Orso; Orina Belton; Lucia Trevisi; Dan A Dixon; Paola Patrignani
Journal:  Br J Pharmacol       Date:  2015-08-03       Impact factor: 8.739

Review 2.  Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus.

Authors:  Tove Lekva; Errol R Norwitz; Pål Aukrust; Thor Ueland
Journal:  Curr Diab Rep       Date:  2016-04       Impact factor: 4.810

3.  Roles of Inflammation and Depression in the Development of Gestational Diabetes.

Authors:  Thalia K Robakis; Linn Aasly; Katherine Ellie Williams; Claire Clark; Natalie Rasgon
Journal:  Curr Behav Neurosci Rep       Date:  2017-10-28

4.  Melatonin Administration Prevents Placental and Fetal Changes Induced by Gestational Diabetes.

Authors:  Ismaela Maria Ferreira de Melo; Cintia Giselle Martins Ferreira; Érique Ricardo Alves; Carolline Guimarães D'Assunção; Clovis José Cavalcanti Lapa Neto; Yuri Mateus Lima de Albuquerque; Valéria Wanderley Teixeira; Álvaro Aguiar Coelho Teixeira
Journal:  Reprod Sci       Date:  2022-01-13       Impact factor: 3.060

5.  Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status.

Authors:  Srinivasa R Nagalla; Caryn K Snyder; John E Michaels; Mary J Laughlin; Charles T Roberts; Madhuri Balaji; V Balaji; V Seshiah; Paturi V Rao
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

6.  GSK3β is increased in adipose tissue and skeletal muscle from women with gestational diabetes where it regulates the inflammatory response.

Authors:  Martha Lappas
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

7.  Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers.

Authors:  Vanessa I Ramirez; Evelyn Miller; Christiane L Meireles; Jonathan Gelfond; Debra A Krummel; Theresa L Powell
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-23

8.  Interleukin 6 (IL-6) and Tumor Necrosis Factor α (TNF-α) Single Nucleotide Polymorphisms (SNPs), Inflammation and Metabolism in Gestational Diabetes Mellitus in Inner Mongolia.

Authors:  Jie Zhang; Haiyi Chi; Huiying Xiao; Xiaoyan Tian; Yilin Wang; Xia Yun; Yancheng Xu
Journal:  Med Sci Monit       Date:  2017-08-28

9.  Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational Diabetes.

Authors:  Friederike Schulze; Josua Wehner; Denise V Kratschmar; Valmir Makshana; Daniel T Meier; Stéphanie P Häuselmann; Elise Dalmas; Constanze Thienel; Erez Dror; Sophia J Wiedemann; Shuyang Traub; Thierry M Nordmann; Leila Rachid; Axel De Baat; Theresa V Rohm; Cheng Zhao; Alex Odermatt; Marianne Böni-Schnetzler; Marc Y Donath
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

10.  Ontology of the apelinergic system in mouse pancreas during pregnancy and relationship with β-cell mass.

Authors:  Brenda Strutt; Sandra Szlapinski; Thineesha Gnaneswaran; Sarah Donegan; Jessica Hill; Jamie Bennett; David J Hill
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.